- Home
- CAAS vs ENTA Comparison
CAAS vs ENTA Comparison
Compare CAAS & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAS
- ENTA
- Stock Information
- Founded
- CAAS N/A
- ENTA 1995
- Country
- CAAS China
- ENTA United States
- Employees
- CAAS N/A
- ENTA N/A
- Industry
- CAAS Auto Parts:O.E.M.
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- CAAS Consumer Discretionary
- ENTA Health Care
- Exchange
- CAAS Nasdaq
- ENTA Nasdaq
- Market Cap
- CAAS 111.1M
- ENTA 127.8M
- IPO Year
- CAAS N/A
- ENTA 2013
- Fundamental
- Price
- CAAS $3.90
- ENTA $6.13
- Analyst Decision
- CAAS
- ENTA Buy
- Analyst Count
- CAAS 0
- ENTA 4
- Target Price
- CAAS N/A
- ENTA $19.50
- AVG Volume (30 Days)
- CAAS 35.5K
- ENTA 464.3K
- Earning Date
- CAAS 11-13-2024
- ENTA 02-05-2025
- Dividend Yield
- CAAS N/A
- ENTA N/A
- EPS Growth
- CAAS 2.02
- ENTA N/A
- EPS
- CAAS 1.05
- ENTA N/A
- Revenue
- CAAS $621,377,000.00
- ENTA $67,635,000.00
- Revenue This Year
- CAAS $4.97
- ENTA $11.80
- Revenue Next Year
- CAAS N/A
- ENTA $3.99
- P/E Ratio
- CAAS $3.99
- ENTA N/A
- Revenue Growth
- CAAS 13.81
- ENTA N/A
- 52 Week Low
- CAAS $3.05
- ENTA $5.84
- 52 Week High
- CAAS $4.97
- ENTA $17.80
- Technical
- Relative Strength Index (RSI)
- CAAS 31.61
- ENTA 25.78
- Support Level
- CAAS $4.32
- ENTA $5.84
- Resistance Level
- CAAS $4.52
- ENTA $6.56
- Average True Range (ATR)
- CAAS 0.19
- ENTA 0.78
- MACD
- CAAS -0.04
- ENTA -0.19
- Stochastic Oscillator
- CAAS 2.86
- ENTA 7.73
About CAAS China Automotive Systems Inc.
China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, more than 310 models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.